<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>iBridge Network Innovations</title>
  <subtitle>The latest innovations on the iBridge Network. Finding the missing link in research just got easier.</subtitle>
  <link href="http://www.ibridgenetwork.org/innovations/feed_list" rel="self"/>
  <link href="http://www.ibridgenetwork.org/" rel="alternate"/>
  <id>http://www.ibridgenetwork.org/innovations/by?type=NilClass</id>
  <updated>2008-05-13T23:11:59Z</updated>
  <author>
    <name>Kauffman Innovation Network, Inc.</name>
    <uri>http://www.ibridgenetwork.org/info/about</uri>
    <email>info@ibridgenetwork.org</email>
  </author>
  <icon>http://www.ibridgenetwork.org/images/feed_icon.gif</icon>
  <rights>Copyright 2008 Kauffman Innovation Network, Inc.</rights>
  <contributor>
    <name>University of California, Davis - UC Davis</name>
  </contributor>
  <contributor>
    <name>Columbia University Science &amp; Technology Ventures </name>
  </contributor>
  <contributor>
    <name>University of Pittsburgh</name>
  </contributor>
  <contributor>
    <name>University of California, Irvine</name>
  </contributor>
  <contributor>
    <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
  </contributor>
  <contributor>
    <name>Michigan Technological University</name>
  </contributor>
  <contributor>
    <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
  </contributor>
  <category term="Environment"/>
  <category term="Transportation"/>
  <category term="Materials"/>
  <category term="Nanotechnology"/>
  <category term="Animal/Veterinary"/>
  <category term="Electrical"/>
  <category term="Diagnostic"/>
  <category term="Genomics/Genetics"/>
  <category term="Proteomics"/>
  <category term="Devices"/>
  <category term="Biomedical"/>
  <category term="Bioinformatics"/>
  <category term="Computer Software"/>
  <category term="Chemicals"/>
  <category term="Therapeutic"/>
  <category term="Gene Therapy"/>
  <category term="Drug Discovery"/>
  <category term="Communication"/>
  <category term="Imaging"/>
  <category term="Optics"/>
  <category term="Drug Screening"/>
  <category term="Agriculture"/>
  <category term="Process/Procedure"/>
  <category term="Computer Hardware"/>
  <entry>
    <title type="html">
Wicking Condensate Evaporator at AC Condenser    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/927" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/927</id>
    <updated>2008-05-13T23:11:59Z</updated>
    <author>
      <name>, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>chakhovs@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Wicking Evaporative Media Portion in Rooftop Air Conditioning Units with No Connections or Moving Parts&lt;/p&gt;    </content>
    <category term="Environment" scheme="http://www.ibridgenetwork.org/browse/by?categories=12"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Carbon Dioxide Reforming of Methane    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/954" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/954</id>
    <updated>2008-05-13T03:45:52Z</updated>
    <author>
      <name>, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>nerashid@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;As-Grown Nanoparticles Immobilized in Single-Wall Carbon Nanotubes for Carbon Dioxide Reforming of Methane&lt;/p&gt;    </content>
    <category term="Transportation" scheme="http://www.ibridgenetwork.org/browse/by?categories=16"/>
    <category term="Materials" scheme="http://www.ibridgenetwork.org/browse/by?categories=21"/>
    <category term="Nanotechnology" scheme="http://www.ibridgenetwork.org/browse/by?categories=22"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
SNP Discovery in Candidate Genes for Cattle Lipid Composition    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/964" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/964</id>
    <updated>2008-05-13T15:22:54Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Markers for Genetic Variation Among Cattle Associated with the Fatty Acid Composition of Milk&lt;/p&gt;    </content>
    <category term="Animal/Veterinary" scheme="http://www.ibridgenetwork.org/browse/by?categories=25"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
High Efficiency, Low Cost Solar Cells    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/966" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/966</id>
    <updated>2008-05-13T20:04:05Z</updated>
    <author>
      <name>, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>nerashid@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Composite Nanostructured Solar Cell Fabricated with Re-usable Substrate&lt;/p&gt;    </content>
    <category term="Electrical" scheme="http://www.ibridgenetwork.org/browse/by?categories=20"/>
    <category term="Materials" scheme="http://www.ibridgenetwork.org/browse/by?categories=21"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Tissue and cell microarray compound for freshly frozen samples    </title>
    <link href="http://www.ibridgenetwork.org/Columbia/tissue-and-cell-microarray-compound-for-freshly-frozen-sample" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/Columbia/tissue-and-cell-microarray-compound-for-freshly-frozen-sample</id>
    <updated>2008-05-13T18:48:58Z</updated>
    <author>
      <name>Jerry Kokoshka, Columbia University Science &amp; Technology Ventures </name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>jk2108@columbia.edu</email>
    </author>
    <content type="html">
&lt;p&gt;&lt;strong&gt;Problem or Unmet Need&lt;/strong&gt;
Tissue microarrays are an emerging technology for the rapid molecular characterization of biopsy and cell culture samples. Arrays are formed by arranging many tissue samples in a block, then slicing them with a microtome; the multi-tissue sheaf may then be immobilized on a glass slide for analysis. Initial arrays could only be used with a limited set of techniques due to the use of fixed, paraffin-embedded tissue. In contrast, frozen tissue is amenable many more assays, including immunohistochemical staining, nucleic acid quantification, and receptor-ligand binding studies. Recently developed arraying techniques embed frozen tissues in a block of Optimal Cutting Temperature compound (OCT). The low temperature needed to keep &lt;span class="caps"&gt;OCT&lt;/span&gt; in solid form complicates microarray fabrication; brittle blocks cracking or repeated freeze-thaw cycles can degrade frozen sections. Furthermore, cell samples placed into the holes of pre-frozen &lt;span class="caps"&gt;OCT&lt;/span&gt; blocks freeze rapidly, causing cell damage. A simple, reliable and cost-efficient method for making frozen cell and tissue microarrays is needed to realize the technology’s potential.&lt;/p&gt;


	&lt;p&gt;&lt;strong&gt;Details of the Invention&lt;/strong&gt;
This invention introduces a new compound of &lt;span class="caps"&gt;OCT&lt;/span&gt; and preserving, non-caustic agents for making housing blocks for frozen tissue and cell microarrays. The resultant compound has the same physical characteristics as &lt;span class="caps"&gt;OCT&lt;/span&gt; at low temperatures (below 0°C), but is able to be flexible and soft in solid phase at temperatures above 0°C. Using the new compound simplifies construction, improves sample preservation and enables novel design of tissue array cryo-blocks for pathology and cell biology research.&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Genomics/Genetics" scheme="http://www.ibridgenetwork.org/browse/by?categories=32"/>
    <category term="Proteomics" scheme="http://www.ibridgenetwork.org/browse/by?categories=33"/>
    <contributor>
      <name>Columbia University Science &amp; Technology Ventures </name>
    </contributor>
    <rights>Copyright 2008, Columbia University Science &amp; Technology Ventures </rights>
  </entry>
  <entry>
    <title type="html">
Impeller Designs for an Internal Impeller Respiratory Assist Catheter (iPRAC)    </title>
    <link href="http://www.ibridgenetwork.org/university-of-pittsburgh/impeller-designs-for-an-internal-impeller-respiratory-assist-" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/university-of-pittsburgh/impeller-designs-for-an-internal-impeller-respiratory-assist-</id>
    <updated>2008-05-13T18:40:35Z</updated>
    <author>
      <name>Carolyn Weber, University of Pittsburgh</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>cjweber@otm.tt.pitt.edu</email>
    </author>
    <content type="html">
&lt;p&gt;This invention involves a small catheter that can be percutaneously inserted into the venous system and used by intensivists to help assist breathing in patients with acute and acute-on-chronic lung failure.&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <contributor>
      <name>University of Pittsburgh</name>
    </contributor>
    <rights>Copyright 2008, University of Pittsburgh</rights>
  </entry>
  <entry>
    <title type="html">
Regulation of Fluid Transfer in a Compact Disk (CD)-Based Microfluidic Device    </title>
    <link href="http://www.ibridgenetwork.org/UCI/regulation-of-fluid-transfer-in-a-compact-disk-cd-based-micro" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/regulation-of-fluid-transfer-in-a-compact-disk-cd-based-micro</id>
    <updated>2008-05-13T21:15:57Z</updated>
    <author>
      <name>, University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>aviray@uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at the University of CA, Irvine have developed a method and apparatus that is capable of regulating fluid flow between the various features and elements contained in CD-based microfluidic devices. This CD-based microfluidic device having multiple chambers therein includes multiple &amp;#8220;start&amp;#8221; chambers or elements for holding and receiving fluid.&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Nanotechnology" scheme="http://www.ibridgenetwork.org/browse/by?categories=22"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Method and device to treat ocular motor disorders    </title>
    <link href="http://www.ibridgenetwork.org/university-of-pittsburgh/method-and-device-to-treat-ocular-motor-disorders" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/university-of-pittsburgh/method-and-device-to-treat-ocular-motor-disorders</id>
    <updated>2008-05-13T08:31:43Z</updated>
    <author>
      <name>Carolyn Weber, University of Pittsburgh</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>cjweber@otm.tt.pitt.edu</email>
    </author>
    <content type="html">
&lt;p&gt;This invention consists of implantable devices and methods for treating unwanted eye movements and strabismus.&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <contributor>
      <name>University of Pittsburgh</name>
    </contributor>
    <rights>Copyright 2008, University of Pittsburgh</rights>
  </entry>
  <entry>
    <title type="html">
Combinatorial approaches to physiologic pattern recognition (CAPPER)    </title>
    <link href="http://www.ibridgenetwork.org/university-of-pittsburgh/combinatorial-approaches-to-physiologic-pattern-recognition-c" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/university-of-pittsburgh/combinatorial-approaches-to-physiologic-pattern-recognition-c</id>
    <updated>2008-05-13T10:31:39Z</updated>
    <author>
      <name>Carolyn Weber, University of Pittsburgh</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>cjweber@otm.tt.pitt.edu</email>
    </author>
    <content type="html">
&lt;p&gt;The inventors have developed a novel algorithm and software for diagnostic, monitoring, and prognostic applications. Populations of interest include those individuals with Sleep Disordered Breathing, Chronic Kidney Disease, those who are critically ill, and those with heart failure or hypertension.&lt;/p&gt;    </content>
    <category term="Bioinformatics" scheme="http://www.ibridgenetwork.org/browse/by?categories=8"/>
    <category term="Computer Software" scheme="http://www.ibridgenetwork.org/browse/by?categories=10"/>
    <contributor>
      <name>University of Pittsburgh</name>
    </contributor>
    <rights>Copyright 2008, University of Pittsburgh</rights>
  </entry>
  <entry>
    <title type="html">
Use of Photosensitized Epon Epoxy Resin 1002F for MEMS and BioMEMS Applications    </title>
    <link href="http://www.ibridgenetwork.org/UCI/use-of-photosensitized-epon-epoxy-resin-1002f-for-mems-and-bi" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/use-of-photosensitized-epon-epoxy-resin-1002f-for-mems-and-bi</id>
    <updated>2008-05-14T01:32:06Z</updated>
    <author>
      <name>Nola Colman, University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>ncolman@research.uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at UC Irvine have found that a certain resin (&amp;#8220;Resin&amp;#8221;) can be made photosensitive in the same way as SU-8, but is neither brittle nor fluorescent. The Resin is already readily available in industry.&lt;/p&gt;    </content>
    <category term="Chemicals" scheme="http://www.ibridgenetwork.org/browse/by?categories=17"/>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Materials" scheme="http://www.ibridgenetwork.org/browse/by?categories=21"/>
    <category term="Nanotechnology" scheme="http://www.ibridgenetwork.org/browse/by?categories=22"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Mitochondrial DNA Variants Associated with Metabolic Syndrome    </title>
    <link href="http://www.ibridgenetwork.org/UCI/mitochondrial-dna-variants-associated-with-metabolic-syndrome" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/mitochondrial-dna-variants-associated-with-metabolic-syndrome</id>
    <updated>2008-05-13T18:40:06Z</updated>
    <author>
      <name>Nola Colman, University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>ncolman@research.uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;We have discovered a number of human mitochondria1 &lt;span class="caps"&gt;DNA&lt;/span&gt; (mtDNA) lineages (haplogroups) that strikingly increase or decrease individual risk for developing the various symptoms of the Metabolic Syndrome (diabetes, obesity, hypertension, serum cholesterol and triglycerides, etc.).&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Therapeutic" scheme="http://www.ibridgenetwork.org/browse/by?categories=15"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <category term="Gene Therapy" scheme="http://www.ibridgenetwork.org/browse/by?categories=31"/>
    <category term="Genomics/Genetics" scheme="http://www.ibridgenetwork.org/browse/by?categories=32"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Compound to Aid in Smoking Cessation    </title>
    <link href="http://www.ibridgenetwork.org/UCI/compound-to-aid-in-smoking-cessation" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/compound-to-aid-in-smoking-cessation</id>
    <updated>2008-05-14T00:55:18Z</updated>
    <author>
      <name>Nola Colman, University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>ncolman@research.uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at the University of California, Irvine (UCI) have shown that monoamine oxidase (MAO) inhibition greatly enhances nicotine self-administration in animals.&lt;/p&gt;    </content>
    <category term="Therapeutic" scheme="http://www.ibridgenetwork.org/browse/by?categories=15"/>
    <category term="Chemicals" scheme="http://www.ibridgenetwork.org/browse/by?categories=17"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <category term="Drug Discovery" scheme="http://www.ibridgenetwork.org/browse/by?categories=29"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Compact Atomic Magnetometer and Gyroscope    </title>
    <link href="http://www.ibridgenetwork.org/UCI/compact-atomic-magnetometer-and-gyroscope" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/compact-atomic-magnetometer-and-gyroscope</id>
    <updated>2008-05-14T00:20:46Z</updated>
    <author>
      <name>Andrei Shkel, Ph.D., University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>ncolman@research.uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;This invention consists of a compact, inexpensive and highly sensitive gyroscope/magnetometer that runs on very low power (eg battery power) and is even suitable for remote deployment or even handheld portable systems. Simple fabrication further enhances the low cost approach of this design.&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Environment" scheme="http://www.ibridgenetwork.org/browse/by?categories=12"/>
    <category term="Transportation" scheme="http://www.ibridgenetwork.org/browse/by?categories=16"/>
    <category term="Communication" scheme="http://www.ibridgenetwork.org/browse/by?categories=18"/>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Electrical" scheme="http://www.ibridgenetwork.org/browse/by?categories=20"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Optical Tomography of Structural Proteins within Extracellular Matrix    </title>
    <link href="http://www.ibridgenetwork.org/UCI/optical-tomography-of-structural-proteins-within-extracellula" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/optical-tomography-of-structural-proteins-within-extracellula</id>
    <updated>2008-05-13T23:25:13Z</updated>
    <author>
      <name>Nola Colman, University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>ncolman@research.uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at the University of California, Irvine have developed a system to image biological tissues with high resolution and 3D capabilities.&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Imaging" scheme="http://www.ibridgenetwork.org/browse/by?categories=13"/>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Optics" scheme="http://www.ibridgenetwork.org/browse/by?categories=23"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Mouse Model of Cardiac and Muscle Disease and Cancer Caused by a Mitochondrial DNA Point Mutation    </title>
    <link href="http://www.ibridgenetwork.org/UCI/mouse-model-of-cardiac-and-muscle-disease-and-cancer-caused-b" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCI/mouse-model-of-cardiac-and-muscle-disease-and-cancer-caused-b</id>
    <updated>2008-05-12T08:28:13Z</updated>
    <author>
      <name>Nola Colman, University of California, Irvine</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>ncolman@research.uci.edu</email>
    </author>
    <content type="html">
&lt;p&gt;UC Irvine researchers report the introduction of a mtDNA harboring a missense mutation in the &lt;span class="caps"&gt;COI&lt;/span&gt; gene into the mouse that predisposes the mice to develop myopathy and hypertrophic cardiomyopathy as well as certain hyperproliferative conditions in an age-related manner.&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Therapeutic" scheme="http://www.ibridgenetwork.org/browse/by?categories=15"/>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <category term="Drug Discovery" scheme="http://www.ibridgenetwork.org/browse/by?categories=29"/>
    <category term="Drug Screening" scheme="http://www.ibridgenetwork.org/browse/by?categories=30"/>
    <category term="Genomics/Genetics" scheme="http://www.ibridgenetwork.org/browse/by?categories=32"/>
    <contributor>
      <name>University of California, Irvine</name>
    </contributor>
    <rights>Copyright 2008, University of California, Irvine</rights>
  </entry>
  <entry>
    <title type="html">
Novel Single Domain Phytochrome-Based&amp;nbsp; Fluorescent Protein    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/918" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/918</id>
    <updated>2008-05-13T00:34:33Z</updated>
    <author>
      <name>Rajagopal Gururajan, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rgururajan@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Isolation and Characterization of a Red Fluorescent Phytochrome-Related Mutant Protein&lt;/p&gt;    </content>
    <category term="Chemicals" scheme="http://www.ibridgenetwork.org/browse/by?categories=17"/>
    <category term="Proteomics" scheme="http://www.ibridgenetwork.org/browse/by?categories=33"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Novel Digital Tonography Methods and Apparatus for Glaucoma Diagnosis    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/940" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/940</id>
    <updated>2008-05-13T10:24:09Z</updated>
    <author>
      <name>Rajagopal Gururajan, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rgururajan@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Real-time Continuous and Direct Measurement of Aqueous Outflow Resistance&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Lyme Disease Assay    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/955" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/955</id>
    <updated>2008-05-13T23:15:59Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Lyme Disease Assay&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Constitutive Promoter in Dicot Plants    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/959" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/959</id>
    <updated>2008-05-12T16:26:33Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Constitutive Promoter in Dicot Plants&lt;/p&gt;    </content>
    <category term="Agriculture" scheme="http://www.ibridgenetwork.org/browse/by?categories=24"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Nod Factor Binding Protein from Legumes    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/958" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/958</id>
    <updated>2008-05-13T05:38:13Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Nod Factor Binding Protein from Legumes&lt;/p&gt;    </content>
    <category term="Agriculture" scheme="http://www.ibridgenetwork.org/browse/by?categories=24"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Candidate Vaccine for Equine Arteritis Virus (EAV)    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/957" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/957</id>
    <updated>2008-05-12T16:30:25Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Candidate Vaccine for Equine Arteritis Virus (EAV)&lt;/p&gt;    </content>
    <category term="Animal/Veterinary" scheme="http://www.ibridgenetwork.org/browse/by?categories=25"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Gene for Resistance to Bacterial Blight Disease    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/956" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/956</id>
    <updated>2008-05-13T03:39:58Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Gene and its Associated Peptide that Confers Resistance to &lt;em&gt;Xanthomonas&lt;/em&gt;&lt;/p&gt;    </content>
    <category term="Agriculture" scheme="http://www.ibridgenetwork.org/browse/by?categories=24"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Pathogen Resistance in Cereals    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/961" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/961</id>
    <updated>2008-05-13T00:03:02Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Pathogen Resistance in Cereals&lt;/p&gt;    </content>
    <category term="Agriculture" scheme="http://www.ibridgenetwork.org/browse/by?categories=24"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Sperm Preservation    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/960" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/960</id>
    <updated>2008-05-12T16:26:49Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Ultrarapid Freezing of Sperm for Long-Term Storage&lt;/p&gt;    </content>
    <category term="Materials" scheme="http://www.ibridgenetwork.org/browse/by?categories=21"/>
    <category term="Genomics/Genetics" scheme="http://www.ibridgenetwork.org/browse/by?categories=32"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
Precision Planting Device    </title>
    <link href="http://www.ibridgenetwork.org/UCDavis/963" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/UCDavis/963</id>
    <updated>2008-05-13T23:30:27Z</updated>
    <author>
      <name>Randi Jenkins, University of California, Davis - UC Davis</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>rljenkins@ucdavis.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Ultra-Precise Seed Planter with Data-Logging&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Agriculture" scheme="http://www.ibridgenetwork.org/browse/by?categories=24"/>
    <contributor>
      <name>University of California, Davis - UC Davis</name>
    </contributor>
    <rights>Copyright 2008, University of California, Davis - UC Davis</rights>
  </entry>
  <entry>
    <title type="html">
3-D Embryonic Stem Cell GFP-Based Fluorescence Assays for High-Throughput Drug Screening, Bioprocess Development, and Biosensing Applications    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/3-d-embryonic-stem-cell-gfp-based-fluorescence-assays-for-hig" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/3-d-embryonic-stem-cell-gfp-based-fluorescence-assays-for-hig</id>
    <updated>2008-05-13T05:25:54Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Mammalian, live-cell, fluorescent, kinetic assays are common tools for the pharmaceutical industry, for safety evaluation agencies and even for basic science research as these assays are highly suitable for automatic high-throughput screening and they enable the characterization of rapid cellular events. However, fluorescent signals generated in such assays are usually too weak for in situ measurements. Researchers at The Ohio State University have developed a three-dimensional (3-D) cell culture system that out-performs conventional 2-D cultures which lack proper in vivo tissue functions and are inherently prone to error. The higher cell density in 3-D cell culture shows differences in drug cytotoxicity responses as compared with those from the 2-D cell culture assays and also gives a potential for higher signal to noise ratio (SNR). &lt;span class="caps"&gt;OSU&lt;/span&gt; has designed, built and tested a high throughput, real time, bioactivity assay based on the 3-D culture of &lt;span class="caps"&gt;GFP&lt;/span&gt;-expressing embryonic stem (ES) cells, which can increase &lt;span class="caps"&gt;SNR&lt;/span&gt; at least one order of magnitude and minimize errors due to biological system changes caused by cell activities as compared to conventional 2-D cultures. The 3-D ES cell culture system using inexpensive materials can afford parallel, automated, accurate and long-term (more than one week) cell bioactivity assays. This system has the potential for use as high-throughput biosensors, micro-bioreactor arrays for bioprocess optimization, cytotoxicity assays for drug screening and discovery, and media optimization for expanding and differentiating embryonic stem cells.&lt;/p&gt;    </content>
    <category term="Process/Procedure" scheme="http://www.ibridgenetwork.org/browse/by?categories=14"/>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <category term="Drug Screening" scheme="http://www.ibridgenetwork.org/browse/by?categories=30"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Beating Heart Surgical Device    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/beating-heart-surgical-device" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/beating-heart-surgical-device</id>
    <updated>2008-05-13T17:55:24Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;There are a variety of surgical procedures that require access to the left ventricle of the heart. Currently these surgical procedures involve placing the patient on a heart-lung bypass machine to allow complete access to the left ventricle with additional risk to the patient. The novel surgical methods and companion devices developed at Ohio State allow access to the left ventricle of a patient during surgery without the need for heart-lung bypass. Interventions including coring and inspection of the interior of the ventricle cavity can be accomplished. By eliminating the need for bypass during surgery patient outcomes may be significantly improved. The new technology allows surgical procedures such as implantation of a left ventricular assist device to be performed without the added complications of placing the patient on the heart-lung machine. &lt;/p&gt;
&lt;p&gt;This reduces complications from:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;use of blood thinning agents &lt;/li&gt;
    &lt;li&gt;mechanical degradation of blood components requiring post-operative transfusions &lt;/li&gt;
    &lt;li&gt;mechanical induced inflammation response &lt;/li&gt;
    &lt;li&gt;increased risk of stroke&lt;/li&gt;
&lt;/ul&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Tunnel and Backwards Diodes and their uses    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/tunnel-and-backwards-diodes-and-their-uses" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/tunnel-and-backwards-diodes-and-their-uses</id>
    <updated>2008-05-13T09:56:35Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at The Ohio State University have developed diodes that use quantum effects known as &amp;ldquo;tunneling&amp;rdquo;. These diodes work at a very low voltage and at room temperature, unlike other tunneling diodes. Additionally, they avoid the use of silicon, instead using polymers and titanium oxide. Other researchers have tried titanium oxide and could not make the combination work. Instead of applying the titanium oxide directly to the polymer, Berger&amp;rsquo;s team applied a thin film of titanium and then oxidized it, giving them greater control over the properties of the diode. This allows the diodes to be manufactured cheaply and easily incorporate into existing technologies. By fashioning two of these diodes together, the research team was able to form a logic switch, a simple computer chip device. The diodes can be used in the following:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;Organic computer chips, augmenting silicon to be used in lightweight, portable electronics that run on less power.&lt;/li&gt;
    &lt;li&gt;Using a tunnel diode with a strong short circuit running backwards will allow a sensor to be build that can &amp;ldquo;see through&amp;rdquo; solid material by sensing ambient radiation.&lt;/li&gt;
&lt;/ul&gt;    </content>
    <category term="Computer Hardware" scheme="http://www.ibridgenetwork.org/browse/by?categories=9"/>
    <category term="Communication" scheme="http://www.ibridgenetwork.org/browse/by?categories=18"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Methods to genetically manipulate human natural killer cells    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/methods-to-genetically-manipulate-human-natural-killer-cells" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/methods-to-genetically-manipulate-human-natural-killer-cells</id>
    <updated>2008-05-13T18:21:38Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at The Ohio State University have developed a novel retrovirus based method to genetically manipulate human natural killer (NK) cells. This retrovirus based approach results in the permanent transduction of NK cells with genetic material. This is in contract to episomal vectors that are lost with cell division / long term cell culture. The method is also the first to result in successful transduction of the CD56dim NK population. The method has been successful with a variety of genes into primary NK and NK-derived cell lines. With the advent of NK cell transplantation in cancer therapy for patients with acute myeloid leukemia, the genetic manipulation of NK cell populations prior to administration may provide therapeutic benefits by enhancing NK cell survival, function, cytokine production, and tumor specific killing.&lt;/p&gt;    </content>
    <category term="Therapeutic" scheme="http://www.ibridgenetwork.org/browse/by?categories=15"/>
    <category term="Drug Discovery" scheme="http://www.ibridgenetwork.org/browse/by?categories=29"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Circulating Plasma DNA Levels as a Biomarker in Dogs with Lymphoid Cancer    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/circulating-plasma-dna-levels-as-a-biomarker-in-dogs-with-lym" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/circulating-plasma-dna-levels-as-a-biomarker-in-dogs-with-lym</id>
    <updated>2008-05-13T17:01:28Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Dogs have a similar incidence of spontaneous cancers as people, and a noninvasive test to monitor disease status in dogs would be of great value. Humans with cancer often have increased levels of cell-free circulating &lt;span class="caps"&gt;DNA&lt;/span&gt;. Researchers at The Ohio State University determined that some dogs with lymphoid malignancies (lymphoma and lymphoid leukemia) have significantly higher concentrations of circulating plasma &lt;span class="caps"&gt;DNA&lt;/span&gt; than normal dogs or dogs that are ill with diseases other than cancer. Antigen receptor rearrangement assays for clonality indicated that plasma &lt;span class="caps"&gt;DNA&lt;/span&gt; had was derived from the primary tumors. Dogs with lymphoid neoplasia and plasma &lt;span class="caps"&gt;DNA&lt;/span&gt; &amp;gt;25ng/ml had shorter remission times than those with &lt;25ng/ml (p=0.0116), suggesting that increased tumor-derived plasma DNA may be a negative prognostic indicator. Monitoring plasma DNA levels in dogs with lymphoid cancer may assist in diagnosis, determining response to treatment, and detecting residual disease.&lt;/p&gt;    </content>
    <category term="Animal/Veterinary" scheme="http://www.ibridgenetwork.org/browse/by?categories=25"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Corrosion Resistant Coating    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/corrosion-resistant-coating" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/corrosion-resistant-coating</id>
    <updated>2008-05-13T09:56:58Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Researchers at the Ohio State University have discovered a novel method to fabricate an inorganic corrosion resistant coating. The invention covers the chemistry and methods of application for an inorganic corrosion resistant coating. The coating may be applied to aluminum, iron, zinc, magnesium, cadmium and their alloys. The coating may also be appropriate for use with other less widely used metals and alloys.&lt;/p&gt;


	&lt;p&gt;Coatings formed by this method possessed good corrosion resistance in lab tests, and the corrosion resistance demonstrated by the vanadium coatings approaches that of chromate coatings that are currently in widespread use. Chromate coatings, however, have several disadvantages that are addressed by using vanadium coatings. First, chromates are known carcinogens, and human exposure to low levels of chromate may have both acute and chronic health consequences. Second, chromates are long-lived in the environment and proper treatment and disposal of chromates is an expensive and hazardous process. Vanadium coatings do not process this level of toxic hazard and represent an environmentally friendly alternative to the existing chromate coatings.&lt;/p&gt;    </content>
    <category term="Materials" scheme="http://www.ibridgenetwork.org/browse/by?categories=21"/>
    <category term="Nanotechnology" scheme="http://www.ibridgenetwork.org/browse/by?categories=22"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Organic Light-Emitting Diodes (OLED) for Solid State Lighting    </title>
    <link href="http://www.ibridgenetwork.org/TLC_OSU/organic-light-emitting-diodes-oled-for-solid-state-lighting" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/TLC_OSU/organic-light-emitting-diodes-oled-for-solid-state-lighting</id>
    <updated>2008-05-13T23:39:45Z</updated>
    <author>
      <name>Mike Coutinho, The Ohio State University,Technology Licensing &amp; Commercialization</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>coutinho.1@osu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;As energy usage becomes more of a concern worldwide each year, researchers at The Ohio State University have developed a lighting solution that uses less electricity and provides a designable spectrum of illumination. Organic Light-Emitting Diodes (OLEDs) are based on organic (carbon based) materials. In contrast to traditional Light-Emitting Diodes (LEDs), which are small point sources used for anything from clocks to televisions to stop lights, OLEDs are made in sheets which provide a diffuse area light source perfect for environmental lighting. Compared to conventional lighting means such as incandescent, fluorescent and halogen lighting, &lt;span class="caps"&gt;OLED&lt;/span&gt; lighting uses less energy and provides the same quality of light or better. OLEDs can also be used for non-traditional lighting approaches such as illuminating walls, floors or draperies as well as point of use lighting such as flashlights and desk lights.&lt;/p&gt;    </content>
    <category term="Optics" scheme="http://www.ibridgenetwork.org/browse/by?categories=23"/>
    <contributor>
      <name>The Ohio State University,Technology Licensing &amp; Commercialization</name>
    </contributor>
    <rights>Copyright 2008, The Ohio State University,Technology Licensing &amp; Commercialization</rights>
  </entry>
  <entry>
    <title type="html">
Modified Luciferase For Chemical Testing    </title>
    <link href="http://www.ibridgenetwork.org/MTU/modified-luciferase-for-chemical-testing" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/MTU/modified-luciferase-for-chemical-testing</id>
    <updated>2008-05-13T03:02:50Z</updated>
    <author>
      <name>David Shonnard, Michigan Technological University</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>jfdiebel@mtu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Testing high-volume production chemicals for toxicity is an increasing priority for manufactures and consumers alike, resulting in a potential multibillion-dollar testing industry. However, no consistently reliable testing methods currently exist.&lt;/p&gt;


	&lt;p&gt;In the past, animal testing was used, but this method is now viewed as cruel and unethical and is expensive and time-consuming as well. In vitro testing of chemicals has gained ground, but current methods of in vitro testing are time-consuming and unreliable because the chemicals interfere with the test response. This problem occurs frequently in a common testing method that uses luciferase, an enzyme from the North American firefly.&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <category term="Chemicals" scheme="http://www.ibridgenetwork.org/browse/by?categories=17"/>
    <contributor>
      <name>Michigan Technological University</name>
    </contributor>
    <rights>Copyright 2008, Michigan Technological University</rights>
  </entry>
  <entry>
    <title type="html">
Rechargeable Nickel Batteries     </title>
    <link href="http://www.ibridgenetwork.org/MTU/rechargeable-nickel-batteries-" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/MTU/rechargeable-nickel-batteries-</id>
    <updated>2008-05-13T07:54:53Z</updated>
    <author>
      <name>Bahne Cornilsen, Michigan Technological University</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>jfdiebel@mtu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Nickel-based batteries have a broad temperature range of operation, a long storage life, a high cycle life, and are easy to maintain. Although these qualities are significant advantages over other battery systems, nickel-based batteries are problematic because they are expensive to manufacture and relatively heavy, which limits their use in portable devices, electric vehicles, and aerospace engineering. In addition, improper disposal of nickel-based batteries can create environmental problems.&lt;/p&gt;    </content>
    <category term="Chemicals" scheme="http://www.ibridgenetwork.org/browse/by?categories=17"/>
    <category term="Electrical" scheme="http://www.ibridgenetwork.org/browse/by?categories=20"/>
    <contributor>
      <name>Michigan Technological University</name>
    </contributor>
    <rights>Copyright 2008, Michigan Technological University</rights>
  </entry>
  <entry>
    <title type="html">
Wireless Positioning System     </title>
    <link href="http://www.ibridgenetwork.org/MTU/wireless-positioning-system-" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/MTU/wireless-positioning-system-</id>
    <updated>2008-05-13T08:09:35Z</updated>
    <author>
      <name>Seyed Zekavat, Michigan Technological University</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>jfdiebel@mtu.edu</email>
    </author>
    <content type="html">
&lt;p&gt;Wireless technologies have made tremendous inroads in commercial products over the last few years, particularly for communication applications. However, these technologies have not been fully utilized for other purposes, especially their ability to track targets and locate objects.&lt;/p&gt;    </content>
    <category term="Communication" scheme="http://www.ibridgenetwork.org/browse/by?categories=18"/>
    <category term="Electrical" scheme="http://www.ibridgenetwork.org/browse/by?categories=20"/>
    <contributor>
      <name>Michigan Technological University</name>
    </contributor>
    <rights>Copyright 2008, Michigan Technological University</rights>
  </entry>
  <entry>
    <title type="html">
Adjustable Dynamic Joint    </title>
    <link href="http://www.ibridgenetwork.org/WARF/adjustable-dynamic-joint" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/adjustable-dynamic-joint</id>
    <updated>2008-05-13T12:38:08Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;In today’s increasingly sedentary and technology-dependant culture, people spend long hours sitting every day. Prolonged sitting has an extensive and well-documented list of negative health effects upon the human body. Next to the common cold, lower back pain is the biggest reason for worker absenteeism. Although sitting requires less physical effort than standing or walking, it puts a great deal of stress upon the lower body. Simply put, the human body is not physiologically suited for extended inactivity.     &lt;p&gt;The &lt;b&gt;Adjustable Dynamic Joint&lt;/b&gt; is a dynamic solution to a static problem.  The ability of the &lt;span class="caps"&gt;ADJ&lt;/span&gt; to continuously redistribute stress across muscles and ligaments provides a revolutionary way to significantly reduce the effects of prolonged sitting upon the human frame. The joint, which provides motion in 360 degrees, allows the user to exercise core muscles with natural daily movements. The &lt;span class="caps"&gt;ADJ&lt;/span&gt; can be fitted into seating in a wide range of environments, such as the home, office or car.  &lt;/p&gt;&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Method for Generating Primate Trophoblasts    </title>
    <link href="http://www.ibridgenetwork.org/WARF/method-for-generating-primate-trophoblasts" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/method-for-generating-primate-trophoblasts</id>
    <updated>2008-05-11T18:40:21Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Embryonic stem cells are undifferentiated cells that can differentiate into a   number of progenitor cell types. A trophoblast is a differentiated cell that is   a precursor of the cells which participate in forming the human placenta.   Trophoblast cells are difficult to isolate and are not readily available for   research. &lt;i&gt;&lt;b&gt;This invention provides the first method to cause a culture of   primate embryonic stem cells to repeatedly, directly, and uniformly   differentiate into trophoblast cells. &lt;/b&gt;&lt;/i&gt;Treating primate (non-human and   human) embryonic stem cells with a single protein induction factor causes the   cells to transform into trophoblast cells. Several protein factors, including   bone morphogenic protein (BMP) 4, &lt;span class="caps"&gt;BMP2&lt;/span&gt;, BMP7, and growth and differentiation   factor 5, can serve as trophoblast-induction factors. Trophoblast cells are   created directly from embryonic stem cells without the intervening step of   forming an embryoid body. This method results in a stable and nearly pure   culture of primate trophoblast cells.&lt;/p&gt;    </content>
    <category term="Drug Discovery" scheme="http://www.ibridgenetwork.org/browse/by?categories=29"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Rapid Shell Building Method and Materials    </title>
    <link href="http://www.ibridgenetwork.org/WARF/rapid-shell-building-method-and-materials" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/rapid-shell-building-method-and-materials</id>
    <updated>2008-05-12T13:24:33Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Investment casting is commonly used to produce high quality metal objects.   The process generally involves creating a thin-walled ceramic shell around a wax   pattern of a part; removing the pattern once the shell has hardened; filling it   with molten metal and letting the metal solidify; and finally conditioning the   metal part after the shell is removed. Creating the shell traditionally involves   dipping the pattern into a slurry of liquid refractory material and then, while   the coat is still wet, sieving dry refractory grains onto the pattern. After the   coat air-dries, dipping and sieving are repeated as many as seven times to   produce the desired, thin-walled shell. This process of dipping, air-drying and   redipping typically takes 24 hours or more.&lt;i&gt;&lt;b&gt; This invention describes a   method of reducing the time required to create a shell for investment casting. &lt;/b&gt;&lt;/i&gt;  After a pattern is coated with a layer of slurry, a stucco coat is applied over   the moist layer.&lt;i&gt;&lt;b&gt; &lt;/b&gt;&lt;/i&gt;The stucco contains an amorphous mineral silicate to   help wick the moisture away from the slurry layer. After 20-60 minutes, the   stucco layer becomes saturated with water. The saturated portion is then blown   off, physically removing water from the shell. Additional slurry and stucco   coats are applied until the desired shell thickness is achieved.&lt;/p&gt;    </content>
    <category term="Materials" scheme="http://www.ibridgenetwork.org/browse/by?categories=21"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Controlled Decoration of Nanostructures with Aerosol Nanoparticles    </title>
    <link href="http://www.ibridgenetwork.org/WARF/controlled-decoration-of-nanostructures-with-aerosol-nanopart" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/controlled-decoration-of-nanostructures-with-aerosol-nanopart</id>
    <updated>2008-05-14T01:09:57Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Composites of nanoparticles arranged on the surface of carbon nanotubes have   many applications, such as nano-electronics, sensors, fuel cells, solar cells   and hydrogen storage. Current methods of making these composites primarily   utilize wet chemistry techniques, which are slow and limited in scope and allow   only limited control of the assembly process. &lt;i&gt;&lt;b&gt;This invention describes an   efficient method of using electrostatic force to coat nanostructures, including   single- and multi-walled carbon nanotubes, with aerosol nanoparticles. &lt;/b&gt;&lt;/i&gt;  First, an electrically conductive nanostructure is created. Then a mini-arc   plasma flow is used to produce an aerosol of charged nanoparticles. When a   voltage is applied to the nanostructure, the charged nanoparticles are attracted   to the nanostructure and attach to its surface.&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Energy from Organic Waste    </title>
    <link href="http://www.ibridgenetwork.org/WARF/energy-from-organic-waste" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/energy-from-organic-waste</id>
    <updated>2008-05-11T10:14:50Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Anaerobic digestion is an attractive waste management option for   high-strength wastes, such as dairy manure and wastewater from food processing   industries. High molecular weight compounds are hydrolyzed into compounds   suitable for use as a source of energy and cell carbon. Non-methane-forming   bacteria then convert these compounds into identifiable, lower molecular weight   intermediate compounds, such as volatile fatty acids. Finally, methane-forming   bacteria convert the intermediate compounds into carbon dioxide and methane in   the form of biogas. This process requires that the two types of bacteria be in   dynamic equilibrium, and the final step takes more than two weeks. &lt;i&gt;&lt;b&gt;This   invention describes alternative technologies, such as anaerobic catalysis or   photocatalysis, which enhance the overall conversion of volatile solids to   biogas to make anaerobic treatment of waste more efficient. &lt;/b&gt;&lt;/i&gt;Both of   these methods use a solid, titanium dioxide-based catalyst material that is   contacted with a liquid or gas containing target reactants, such as the   intermediate compounds created during the second step of the anaerobic digestion   process. Either heat (catalysis) or UV light (photocatalysis) may be used to   facilitate the reaction on the solid material. Because these methods convert the   intermediate compounds into carbon dioxide and biogas chemically, rather than   biologically, the need for slow growing, methane-forming bacteria in the final   step is eliminated.&lt;/p&gt;    </content>
    <category term="Environment" scheme="http://www.ibridgenetwork.org/browse/by?categories=12"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
A Bioluminescent Gram-Negative Coccus, Photococcus Caeruleum    </title>
    <link href="http://www.ibridgenetwork.org/WARF/a-bioluminescent-gram-negative-coccus-photococcus-caeruleum" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/a-bioluminescent-gram-negative-coccus-photococcus-caeruleum</id>
    <updated>2008-05-13T09:32:02Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;All known bioluminescent bacteria are gram-negative and shaped like a short,   straight or curved rod. They can grow under aerobic or anaerobic conditions and   are able to ferment. &lt;i&gt;&lt;b&gt;This invention describes a novel bioluminescent   bacterium, &lt;/i&gt;Photococcus caeruleum&lt;i&gt;, isolated from the surface of marine   shrimp.&lt;/i&gt;&lt;/b&gt; While &lt;i&gt;P. caeruleum&lt;/i&gt; is most closely related to members of   the genus &lt;i&gt;Photobacterium&lt;/i&gt;, its spherical shape, growth and biochemical   characteristics clearly distinguish it. This isolate, strain &lt;span class="caps"&gt;BC1&lt;/span&gt;, is catalase   and oxidase positive but unable to utilize maltose as a sole carbon and energy   source. It is a gram-negative, non-motile bacterium that produces DNase and   requires oxygen to grow. Strain &lt;span class="caps"&gt;BC1&lt;/span&gt; grows optimally at 27ºC and pH 6.5-7.5.&lt;/p&gt;    </content>
    <category term="Genomics/Genetics" scheme="http://www.ibridgenetwork.org/browse/by?categories=32"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Countermeasures Against Osteoporosis by Novel Multiple Intensity Mechanical Stimulation (NOMIMS)    </title>
    <link href="http://www.ibridgenetwork.org/WARF/countermeasures-against-osteoporosis-by-novel-multiple-intens" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/countermeasures-against-osteoporosis-by-novel-multiple-intens</id>
    <updated>2008-05-13T12:10:40Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Whole body vibration is often used to prevent or combat osteoporosis in the   elderly. A vibrating platform stimulates tissue to increase muscle growth and   bone mineral density. Different muscle and bone tissues resonate at different   frequencies, but the current platforms vibrate sinusoidally at a single   frequency and intensity. &lt;i&gt;&lt;b&gt;This invention features a platform that   stimulates multiple muscle and bone groups simultaneously by vibrating at twelve   different frequencies and intensities. &lt;/b&gt;&lt;/i&gt;A set of four rotating actuators   support the platform. Each actuator is shaped like a rounded, irregular polygon,   with twelve different radii around a center point. As the actuators rotate   together, the platform moves up and down at varying heights, from one-sixteenth   to five-sixteenths of an inch. The higher the peak, the longer it takes the   platform to reach it, creating twelve different frequencies per rotation, and   then pausing.&lt;/p&gt;    </content>
    <category term="Biomedical" scheme="http://www.ibridgenetwork.org/browse/by?categories=26"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Therapeutics for Treating Alcoholism and Seizures    </title>
    <link href="http://www.ibridgenetwork.org/WARF/therapeutics-for-treating-alcoholism-and-seizures" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/therapeutics-for-treating-alcoholism-and-seizures</id>
    <updated>2008-05-13T09:43:47Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Although compounds that bind to neurotransmitter receptors, such as gamma-aminobutyric   acid (GABA) receptors, are used to reduce anxiety, they can also induce sedation   and hypnosis. The inventors previously developed compounds that targeted   specific &lt;span class="caps"&gt;GABA&lt;/span&gt; receptors to treat anxiety with fewer undesirable side effects   (See WiSys Reference Number &lt;span class="caps"&gt;T02017US&lt;/span&gt;). &lt;i&gt;&lt;b&gt;This invention describes the use of   these stereospecific benzodiazepine derivatives as anticonvulsants. &lt;/b&gt;&lt;/i&gt;When   administered to patients, they decrease anxiety or treat convulsant disorders   with reduced sedative, hypnotic, muscle relaxant, and ataxic effects. In   addition, these compounds can diminish alcohol craving and self administration   in alcoholics.&lt;/p&gt;    </content>
    <category term="Drug Discovery" scheme="http://www.ibridgenetwork.org/browse/by?categories=29"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Prefabricated Panels for Temporary Structures    </title>
    <link href="http://www.ibridgenetwork.org/WARF/prefabricated-panels-for-temporary-structures" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/prefabricated-panels-for-temporary-structures</id>
    <updated>2008-05-12T08:32:02Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Temporary structures are often used to provide quick shelter from the   elements or to partition indoor space. They must disassemble and be durable and   reusable. Many systems exist for creating temporary structures, but most require   many different parts. &lt;i&gt;&lt;b&gt;This invention describes a standardized panel and   clip-based system for easily assembling temporary, prefabricated indoor or   outdoor structures.&lt;/b&gt;&lt;/i&gt; The panels come in several different sizes and two   shapes, rectangular and triangular. They are synthetic, with a lip around the   inside that has notches at designated intervals. The releasable clips fit over   the lip when the notches are aligned and slide laterally to secure the panels   together.&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Compounds Related to Capsaicin; Potential New Analgesic Agents    </title>
    <link href="http://www.ibridgenetwork.org/WARF/compounds-related-to-capsaicin-potential-new-analgesic-agents" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/compounds-related-to-capsaicin-potential-new-analgesic-agents</id>
    <updated>2008-05-12T06:56:21Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Capsaicin, a member of the vanilloid class of compounds, is the irritant   compound in hot peppers. Capsaicin derivatives, along with &lt;span class="caps"&gt;TRPV1&lt;/span&gt;, a specific   receptor for vanilloids, are an exciting area of research in the analgesic   field. &lt;i&gt;&lt;b&gt;This biological material provides four new capsaicin derivatives.&lt;/b&gt;&lt;/i&gt;   These compounds were rationally engineered to include modifications likely to   affect &lt;span class="caps"&gt;TRPV1&lt;/span&gt; receptor response.&lt;/p&gt;    </content>
    <category term="Therapeutic" scheme="http://www.ibridgenetwork.org/browse/by?categories=15"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Nanoscale Corona Discharge Electrode    </title>
    <link href="http://www.ibridgenetwork.org/WARF/nanoscale-corona-discharge-electrode" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/nanoscale-corona-discharge-electrode</id>
    <updated>2008-05-13T07:11:50Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Corona discharge is a process by which an electric field near a discharge electrode ionizes air to produce an electrical current between two electrodes.  It has many industrial applications, including manufacturing ozone, scrubbing air particles in air-conditioning systems, removing unwanted volatile organics, and photocopying.  But electrostatic photocopiers and other office machines that utilize corona discharge produce small amounts of ozone, which can be a health hazard.  Current techniques to reduce ozone production and power consumption employ wire electrodes with radii as small as one micrometer; however, the ability to further decrease wire size is limited by practical considerations of wire strength and durability.  &lt;i&gt;&lt;b&gt;This invention describes the use of nanotubes and other nano-objects as corona discharge electrodes. &lt;/b&gt;&lt;/i&gt;  A metal wire or plate, or other conductive substrate can be coated with nanostructures, such as carbon nanotubes, to produce a robust discharge electrode with a small radius of curvature.  These novel corona ion sources provide high ion concentration and high charging efficiency with minimal ozone production.&lt;/p&gt;    </content>
    <category term="Environment" scheme="http://www.ibridgenetwork.org/browse/by?categories=12"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Resealable Clear Flexible Package for Shoes    </title>
    <link href="http://www.ibridgenetwork.org/WARF/resealable-clear-flexible-package-for-shoes" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/resealable-clear-flexible-package-for-shoes</id>
    <updated>2008-05-12T13:04:14Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Shoeboxes protect shoes during shipping, but they take up space even when   empty and must be removed from the shelf and opened to see the shoes. They also   require folding and glue to assemble. Shoe bags are one alternative to shoeboxes   that make shoes visible. &lt;i&gt;&lt;b&gt;This invention provides see-through packaging   that protects shoes and is less expensive to manufacture and ship than   shoeboxes.&lt;/b&gt;&lt;/i&gt; The packaging consists of a piece of stiff material like   cardboard and a plastic bag. The rigid insert provides a base for the shoes to   sit on and three fold up sides that extend higher than the shoes. The plastic   bag fits over the base and keeps the sides folded up without any adhesive. The   bag is closed by either a drawstring or a plastic zipper, and may include a   reinforced hole so that the shoes can be hung from a peg. The shoes can be seen   from all sides, if the insert is transparent, and slipped out of the   packaging via the fourth open side.&lt;/p&gt;    </content>
    <category term="Devices" scheme="http://www.ibridgenetwork.org/browse/by?categories=19"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Anti-anxiety Agents with Reduced Sedative and Ataxic Effects    </title>
    <link href="http://www.ibridgenetwork.org/WARF/anti-anxiety-agents-with-reduced-sedative-and-ataxic-effects" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/anti-anxiety-agents-with-reduced-sedative-and-ataxic-effects</id>
    <updated>2008-05-12T12:34:10Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Anxiety disorders are treated with anti-anxiety drugs (anxiolytics). Most   anxiolytics currently on the market cause adverse side effects such as   drowsiness, dizziness, impaired memory, and decreased coordination. &lt;i&gt;&lt;b&gt;This   invention provides orally active benzodiazepine derivatives that possess   enhanced anxiolytic activity and greatly reduced side effects. &lt;/b&gt;&lt;/i&gt;Gamma   aminobutyric acid (GABA) is the major inhibitory neurotransmitter. The inventors   modified elements of known benzodiazepine agents to create compounds with   enhanced agonist efficacy at certain &lt;span class="caps"&gt;GABA&lt;/span&gt; type A receptor subtypes. This change   led to agents showing enhanced anxiolytic activity and little or no sedative,   hypnotic, and muscle relaxant activities. Several of the modified   benzodiazepines were tested orally in rats and found to reduce situational   anxiety without causing significant sedation, muscle relaxation or ataxic   effects.&lt;/p&gt;    </content>
    <category term="Drug Discovery" scheme="http://www.ibridgenetwork.org/browse/by?categories=29"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Use of Electrical Property Enhanced Tomography to Detect Tumors in Homogeneous Tissues    </title>
    <link href="http://www.ibridgenetwork.org/WARF/use-of-electrical-property-enhanced-tomography-to-detect-tumo" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/use-of-electrical-property-enhanced-tomography-to-detect-tumo</id>
    <updated>2008-05-13T18:36:33Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;Electrical property enhanced tomography (EPET) is a new medical imaging   modality that maps the electrical properties of the body’s tissues to produce   high resolution images of internal structures. &lt;i&gt;&lt;b&gt;This technology is an &lt;span class="caps"&gt;EPET&lt;/span&gt;   method for identifying cancerous tumors within homogeneous tissues of the body,   especially breast tissue. &lt;/b&gt;&lt;/i&gt;The method works by first locating the outer   boundary of an object, such as the human breast, and detecting the accumulated   electrical charge at that boundary when a known voltage is applied. This   peripheral boundary is detected by using arrays of sensors that interleave with   the &lt;span class="caps"&gt;EPET&lt;/span&gt; scanner’s standard sensors for making electrical property measurements.   Once the object’s exterior shape is known, &lt;span class="caps"&gt;EPET&lt;/span&gt; can be used to estimate the   electrical properties within the object. When located inside otherwise   homogeneous tissue, anomalies such as tumors contribute additional accumulated   charge on &lt;span class="caps"&gt;EPET&lt;/span&gt; sensors. This extra charge can then be used to locate and measure   the size and electrical properties of the tumors.&lt;/p&gt;    </content>
    <category term="Diagnostic" scheme="http://www.ibridgenetwork.org/browse/by?categories=11"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
  <entry>
    <title type="html">
Winter-Hardy Plum Cultivar for Wisconsin    </title>
    <link href="http://www.ibridgenetwork.org/WARF/winter-hardy-plum-cultivar-for-wisconsin" rel="alternate"/>
    <id>http://www.ibridgenetwork.org/WARF/winter-hardy-plum-cultivar-for-wisconsin</id>
    <updated>2008-05-13T11:27:11Z</updated>
    <author>
      <name>Emily Bauer, Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
      <uri>http://www.ibridgenetwork.org/info/about</uri>
      <email>licensing@warf.org</email>
    </author>
    <content type="html">
&lt;p&gt;&lt;b&gt;&lt;i&gt;A plant breeder who specializes in the development   of winter-hardy fruits has now produced a winter-hardy plum cultivar called   ‘Lydecker’ for the fresh market. &lt;/i&gt;&lt;/b&gt;Lydecker is the result of a cross   between the ‘Oka’ cherry plum and a conventional Japanese dessert plum (&lt;i&gt;Prunus   salicina&lt;/i&gt;) known as ‘Z’s Blue Giant.’  Oka has in its lineage &lt;i&gt;P. besseyi,  &lt;/i&gt;a native North American plum species adapted to northern climes. &lt;i&gt;P.   besseyi&lt;/i&gt; can withstand severe winters and generally is more productive and   ripens one month earlier than &lt;i&gt;P. americana&lt;/i&gt;, a native plum more commonly   used to produce hardiness in new hybrids.  Lydecker yields fruit that rivals   many California-grown dessert plums in flavor and appearance, and matures two to   four weeks earlier than any other large, high-quality plum grown in the   Midwestern U.S. Lydecker also grows and yields fruit in the U.S. Department of   Agriculture’s hardiness zone 3b (-30 to -35 degrees Fahrenheit) and above,   making it suitable for production in northern climates.  Lydecker exhibits a   naturally compact growth habit and good graft compatibility with most common   plum rootstocks. The new plum cultivar also shows average susceptibility to   brown rot (&lt;i&gt;Monilinia&lt;/i&gt; &lt;i&gt;fructicola&lt;/i&gt;) and black knot (&lt;i&gt;Dibotryon   morbosum&lt;/i&gt;), and is more tolerant to bacterial spot (&lt;i&gt;Xanthomonas campestris&lt;/i&gt;   pv. Pruni) when compared to most Japanese-American hybrids grown in the Midwest.&lt;/p&gt;    </content>
    <category term="Agriculture" scheme="http://www.ibridgenetwork.org/browse/by?categories=24"/>
    <contributor>
      <name>Wisconsin Alumni Research Foundation (University of Wisconsin)</name>
    </contributor>
    <rights>Copyright 2008, Wisconsin Alumni Research Foundation (University of Wisconsin)</rights>
  </entry>
</feed>
